HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Related articles in The JI Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Shilling, R. A. Articles by Sperling, A. I. Search for Related Content PubMed PubMed Citation Articles by Shilling, R. A. Articles by Sperling, A. I.

Cutting Edge: Polymorphisms in the ICOS Promoter Region Are Associated with Allergic Sensitization and Th2 Cytokine Production ¹

Rebecca A. Shilling^2,*, Jayant M. Pinto^2,,, Donna C. Decker^*, Daniel H. Schneider, Hozefa S. Bandukwala, Jeffrey R. Schneider^*, Blanca Camoretti-Mercado^*, Carole Ober and Anne I. Sperling^3,*,

^* Section of Pulmonary and Critical Care Medicine, Department of Medicine, Section of Otolaryngology-Head and Neck Surgery, Department of Surgery, Department of Human Genetics, and Committee on Immunology, The University of Chicago, Chicago, IL 60637

The establishment of ICOS as an important regulator of Th2 development and effector function makes the ICOS locus an attractive candidate for Th2-mediated diseases, such as asthma and allergy. In evaluation of this candidate locus in humans, we identified 11 variants and determined that two in the putative promoter region are significantly associated with allergic sensitization and serum IgE levels. In addition, cultures of activated PBMCs from individuals homozygous for the associated polymorphisms produced increased levels of the Th2 cytokines, IL-4, IL-5, and IL-13, as well as TNF- compared with controls. One of the polymorphisms, –1413G/A, demonstrated differential NF-B binding in mobility shift analysis, suggesting that this polymorphism has functional consequences. Overall, these data demonstrate that ICOS is a susceptibility gene for allergic sensitization, perhaps through the promotion of Th2 differentiation.

Related articles in The JI:

IN THIS ISSUE

The JI 2005 175: 2039-2040. [Full Text]  

This article has been cited by other articles:

				T. Kallinich, K. C. Beier, U. Wahn, P. Stock, and E. Hamelmann T-cell co-stimulatory molecules: their role in allergic immune reactions Eur. Respir. J., June 1, 2007; 29(6): 1246 - 1255. [Abstract] [Full Text] [PDF]

				V. Butty, M. Roy, P. Sabeti, W. Besse, C. Benoist, and D. Mathis Signatures of strong population differentiation shape extended haplotypes across the human CD28, CTLA4, and ICOS costimulatory genes PNAS, January 9, 2007; 104(2): 570 - 575. [Abstract] [Full Text] [PDF]

				A. H.-M. Tan, S.-C. Wong, and K.-P. Lam Regulation of Mouse Inducible Costimulator (ICOS) Expression by Fyn-NFATc2 and ERK Signaling in T Cells J. Biol. Chem., September 29, 2006; 281(39): 28666 - 28678. [Abstract] [Full Text] [PDF]

				E. H. Wilson, C. Zaph, M. Mohrs, A. Welcher, J. Siu, D. Artis, and C. A. Hunter B7RP-1-ICOS Interactions Are Required for Optimal Infection-Induced Expansion of CD4+ Th1 and Th2 Responses J. Immunol., August 15, 2006; 177(4): 2365 - 2372. [Abstract] [Full Text] [PDF]